1,263 results on '"Amnestic mild cognitive impairment"'
Search Results
2. Noninvasive Brain Stimulation on Memory in Individuals With Mild Cognitive Impairment and History of Brain Injury
- Author
-
U.S. Army Medical Research and Development Command and Christian Lobue, Assistant Professor
- Published
- 2024
3. Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
- Author
-
National Institute on Deafness and Other Communication Disorders (NIDCD) and Pamela Souza, Professor and Chair
- Published
- 2024
4. Sleep Interventions and Neurocognitive Outcomes
- Author
-
Columbia University and Hyun "Monica" Kim, Assistant Professor of Clinical Psychology
- Published
- 2024
5. Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment
- Author
-
Philip Gerretsen, Clinician Scientist
- Published
- 2024
6. CSF neurogranin levels as a biomarker in Alzheimer's disease and frontotemporal lobar degeneration: a cross-sectional analysis.
- Author
-
Jurasova, Vanesa, Andel, Ross, Katonova, Alzbeta, Veverova, Katerina, Zuntychova, Terezie, Horakova, Hana, Vyhnalek, Martin, Kolarova, Tereza, Matoska, Vaclav, Blennow, Kaj, and Hort, Jakub
- Subjects
- *
AMNESTIC mild cognitive impairment , *ALZHEIMER'S disease , *ANALYSIS of covariance , *CEREBROSPINAL fluid , *COGNITIVE ability , *APOLIPOPROTEIN E , *FRONTOTEMPORAL lobar degeneration - Abstract
Background: There is initial evidence suggesting that biomarker neurogranin (Ng) may distinguish Alzheimer's disease (AD) from other neurodegenerative diseases. Therefore, we assessed (a) the discriminant ability of cerebrospinal fluid (CSF) Ng levels to distinguish between AD and frontotemporal lobar degeneration (FTLD) pathology and between different stages within the same disease, (b) the relationship between Ng levels and cognitive performance in both AD and FTLD pathology, and (c) whether CSF Ng levels vary by apolipoprotein E (APOE) polymorphism in the AD continuum. Methods: Participants with subjective cognitive decline (SCD) (n = 33), amnestic mild cognitive impairment (aMCI) due to AD (n = 109), AD dementia (n = 67), MCI due to FTLD (n = 25), and FTLD dementia (n = 29) were recruited from the Czech Brain Aging Study. One-way analysis of covariance (ANCOVA) assessed Ng levels in diagnostic subgroups. Linear regressions evaluated the relationship between CSF Ng levels, memory scores, and APOE polymorphism. Results: Ng levels were higher in aMCI-AD patients compared to MCI-FTLD (F[1, 134] = 15.16, p <.001), and in AD-dementia compared to FTLD-dementia (F[1, 96] = 4.60, p =.029). Additionally, Ng levels were higher in FTLD-dementia patients compared to MCI-FTLD (F[1, 54]= 4.35, p =.034), lower in SCD participants compared to aMCI-AD (F[1, 142] = 10.72, p =.001) and AD-dementia (F[1, 100] = 20.90, p <.001), and did not differ between SCD participants and MCI-FTLD (F[1, 58]= 1.02, p =.491) or FTLD-dementia (F[1, 62]= 2.27, p =.051). The main effect of diagnosis across the diagnostic subgroups on Aβ1−42/Ng ratio was significant too (F[4, 263]=, p <.001). We found a non-significant association between Ng levels and memory scores overall (β=-0.25, p =.154) or in AD diagnostic subgroups, and non-significant differences in this association between overall AD APOE ε4 carriers and non-carriers (β=-0.32, p =.358). Conclusions: In this first study to-date to assess MCI and dementia due to AD or FTLD within one study, elevated CSF Ng appears to be an early biomarker of AD-related impairment, but its role as a biomarker appears to diminish after dementia diagnosis, whereby dementia-related underlying processes in AD and FTLD may begin to merge. The Aβ1−42/Ng ratio discriminated AD from FTLD patients better than Ng alone. CSF Ng levels were not related to memory in AD or FTLD, suggesting that Ng may be a marker of the biological signs of disease state rather than cognitive deficits. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. The effects of repetitive transcranial magnetic and transcranial direct current stimulation on memory functions in older adults with mild cognitive impairment: a systematic review and meta-analysis.
- Author
-
Mengdie Hu, Michael A. Nitsche, Yanxin Lv, Hairong Han, Xu Lin, and Fengxue Qi
- Subjects
TRANSCRANIAL magnetic stimulation ,TRANSCRANIAL direct current stimulation ,VISUAL memory ,EXECUTIVE function ,RECOLLECTION (Psychology) ,AMNESTIC mild cognitive impairment ,COGNITIVE neuroscience - Abstract
This document is a list of references for scientific studies on the use of non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS), in the treatment of cognitive impairment and neurological disorders. The studies cover various topics related to memory function, cognitive performance, and brain connectivity in individuals with conditions like mild cognitive impairment and Alzheimer's disease. The document also includes meta-analyses and systematic reviews that summarize the findings of multiple studies in these areas. Library patrons can use this document to explore further research on the topic. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
8. fNIRS as a biomarker for individuals with subjective memory complaints and MCI.
- Author
-
Lee, Tsz‐lok, Guo, Lizhi, and Chan, Agnes S.
- Abstract
INTRODUCTION: Identifying individuals at risk of developing dementia is crucial for early intervention. Mild cognitive impairment (MCI) and subjective memory complaints (SMCs) are considered its preceding stages. This study aimed to assess the utility of functional near‐infrared spectroscopy (fNIRS) in identifying individuals with MCI and SMC. METHODS: One hundred fifty‐one participants were categorized into normal cognition (NC); amnestic MCI (aMCI); non‐amnestic MCI (naMCI); and mild, moderate, and severe SMC groups. Task‐related prefrontal hemodynamics were measured using fNIRS during a visual memory span task. RESULTS: Results showed significantly lower oxyhemoglobin (HbO) levels in aMCI, but not in naMCI, compared to the NC. In addition, severe SMC had lower HbO levels than the NC, mild, and moderate SMC. Receiver operating characteristic analysis demonstrated 69.23% and 69.70% accuracy in differentiating aMCI and severe SMC from NC, respectively. DISCUSSION: FNIRS may serve as a potential non‐invasive biomarker for early detection of dementia. Highlights: Only amnestic mild cognitive impairment (aMCI), but not non‐amnestic MCI, showed lower oxyhemoglobin (HbO) than normal individuals.Reduced HbO was observed in those with severe subjective memory complaints (SMCs) compared to normal cognition (NC), mild, and moderate SMCs.Functional near‐infrared spectroscopy measures were associated with performance in memory assessments.Prefrontal hemodynamics could distinguish aMCI and severe SMC from NC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Detection of cerebrospinal fluid biomarkers changes of Alzheimer's disease using a cognitive stress test in persons with subjective cognitive decline and mild cognitive impairment.
- Author
-
Valles-Salgado, Maria, Gil-Moreno, María José, Curiel Cid, Rosie E., Delgado-Álvarez, Alfonso, Ortega-Madueño, Isabel, Delgado-Alonso, Cristina, Palacios-Sarmiento, Marta, López-Carbonero, Juan I., Cárdenas, María Cruz, Matías-Guiu, Jorge, Díez-Cirarda, María, Loewenstein, David A., and Matias-Guiu, Jordi A.
- Subjects
MILD cognitive impairment ,ALZHEIMER'S disease ,COGNITIVE testing ,AMNESTIC mild cognitive impairment ,CEREBROSPINAL fluid ,LEXICAL access - Abstract
Introduction: Timely and accurate diagnosis of the earliest manifestations of Alzheimer's disease (AD) is critically important. Cognitive challenge tests such as the Loewenstein Acevedo Scales for Semantic Interference and Learning (LASSI-L) have shown favorable diagnostic properties in a number of previous investigations using amyloid or FDG PET. However, no studies have examined LASSI-L performance against cerebrospinal fluid biomarkers of AD, which can be affected before the distribution of fibrillar amyloid and other changes that can be observed in brain neuroimaging. Therefore, we aimed to evaluate the relationship between LASSI-L scores and CSF biomarkers and the capacity of the cognitive challenge test to detect the presence of amyloid and tau deposition in patients with subjective cognitive decline and amnestic mild cognitive impairment (MCI). Methods: One hundred and seventy-nine patients consulting for memory loss without functional impairment were enrolled. Patients were examined using comprehensive neuropsychological assessment, the LASSI-L, and cerebrospinal fluid (CSF) biomarkers (Aβ1-42/Aβ1-40 and ptau181). Means comparisons, correlations, effect sizes, and ROC curves were calculated. Results: LASSI-L scores were significantly associated with CSF biomarkers Aβ1-42/Aβ1-40 in patients diagnosed with MCI and subjective cognitive decline, especially those scores evaluating the capacity to recover from proactive semantic interference effects and delayed recall. A logistic regression model for the entire sample including LASSI-L and age showed an accuracy of 0.749 and an area under the curve of 0.785 to detect abnormal amyloid deposition. Conclusion: Our study supports the biological validity of the LASSI-L and its semantic interference paradigm in the context of the early stages of AD. These findings emphasize the utility and the convenience of including sensitive cognitive challenge tests in the assessment of patients with suspicion of early stages of AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's disease signature regions and predicted future tau deposition.
- Author
-
Hu, Qili, Shi, Mengqiu, Li, Yunfei, and Zhao, Xiaohu
- Subjects
- *
ALZHEIMER'S disease , *AMNESTIC mild cognitive impairment , *TAU proteins , *CYTOPLASMIC filaments , *BRAIN imaging - Abstract
Background: Neurofilament Light (NfL) is a biomarker for early neurodegeneration in Alzheimer's disease (AD). This study aims to examine the association between plasma NfL and multi-modal neuroimaging features across the AD spectrum and whether NfL predicts future tau deposition. Methods: The present study recruited 517 participants comprising Aβ negative cognitively normal (CN-) participants (n = 135), Aβ positive cognitively normal (CN +) participants (n = 64), individuals with amnestic mild cognitive impairment (aMCI) (n = 212), and those diagnosed with AD dementia (n = 106). All the participants underwent multi-modal neuroimaging examinations. Cross-sectional and longitudinal associations between plasma NfL and multi-modal neuro-imaging features were evaluated using partial correlation analysis and linear mixed effects models. We also used linear regression analysis to investigate the association of baseline plasma NfL with future PET tau load. Mediation analysis was used to explore whether the effect of NfL on cognition was mediated by these imaging biomarkers. Results: The results showed that baseline NfL levels and the rate of change were associated with Aβ deposition, brain atrophy, brain connectome, glucose metabolism, and brain perfusion in AD signature regions (P<0.05). In both Aβ positive CN and MCI participants, baseline NfL showed a significant predictive value of elevating tau burden in the left medial orbitofrontal cortex and para-hippocampus (β = 0.336, P = 0.032; β = 0.313, P = 0.047). Lastly, the multi-modal neuroimaging features mediated the association between plasma NfL and cognitive performance. Conclusions: The study supports the association between plasma NfL and multi-modal neuroimaging features in AD-vulnerable regions and its predictive value for future tau deposition. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Machine Learning Classification of Patients with Amnestic Mild Cognitive Impairment and Non-Amnestic Mild Cognitive Impairment from Written Picture Description Tasks.
- Author
-
Kim, Hana, Hillis, Argye E., and Themistocleous, Charalambos
- Subjects
- *
AMNESTIC mild cognitive impairment , *MILD cognitive impairment , *NATURAL language processing , *LANGUAGE models , *LINGUISTIC change - Abstract
Individuals with Mild Cognitive Impairment (MCI), a transitional stage between cognitively healthy aging and dementia, are characterized by subtle neurocognitive changes. Clinically, they can be grouped into two main variants, namely patients with amnestic MCI (aMCI) and non-amnestic MCI (naMCI). The distinction of the two variants is known to be clinically significant as they exhibit different progression rates to dementia. However, it has been particularly challenging to classify the two variants robustly. Recent research indicates that linguistic changes may manifest as one of the early indicators of pathology. Therefore, we focused on MCI's discourse-level writing samples in this study. We hypothesized that a written picture description task can provide information that can be used as an ecological, cost-effective classification system between the two variants. We included one hundred sixty-nine individuals diagnosed with either aMCI or naMCI who received neurophysiological evaluations in addition to a short, written picture description task. Natural Language Processing (NLP) and a BERT pre-trained language model were utilized to analyze the writing samples. We showed that the written picture description task provided 90% overall classification accuracy for the best classification models, which performed better than cognitive measures. Written discourses analyzed by AI models can automatically assess individuals with aMCI and naMCI and facilitate diagnosis, prognosis, therapy planning, and evaluation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Gamma neuromodulation improves episodic memory and its associated network in amnestic mild cognitive impairment: a pilot study
- Author
-
Jones, Kevin T, Gallen, Courtney L, Ostrand, Avery E, Rojas, Julio C, Wais, Peter, Rini, James, Chan, Brandon, Lago, Argentina Lario, Boxer, Adam, Zhao, Min, Gazzaley, Adam, and Zanto, Theodore P
- Subjects
Pharmacology and Pharmaceutical Sciences ,Biomedical and Clinical Sciences ,Brain Disorders ,Dementia ,Acquired Cognitive Impairment ,Alzheimer's Disease ,Clinical Trials and Supportive Activities ,Clinical Research ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Neurodegenerative ,Aging ,Neurosciences ,2.1 Biological and endogenous factors ,Neurological ,Mental health ,Humans ,Brain ,Memory ,Episodic ,Pilot Projects ,Alzheimer Disease ,Magnetic Resonance Imaging ,Cognitive Dysfunction ,Amnestic mild cognitive impairment ,Neurostimulation ,Gamma stimulation ,Episodic memory ,Resting-state functional connectivity ,Clinical Sciences ,Neurology & Neurosurgery ,Biological psychology - Abstract
Amnestic mild cognitive impairment (aMCI) is a predementia stage of Alzheimer's disease associated with dysfunctional episodic memory and limited treatment options. We aimed to characterize feasibility, clinical, and biomarker effects of noninvasive neurostimulation for aMCI. 13 individuals with aMCI received eight 60-minute sessions of 40-Hz (gamma) transcranial alternating current stimulation (tACS) targeting regions related to episodic memory processing. Feasibility, episodic memory, and plasma Alzheimer's disease biomarkers were assessed. Neuroplastic changes were characterized by resting-state functional connectivity (RSFC) and neuronal excitatory/inhibitory balance. Gamma tACS was feasible and aMCI participants demonstrated improvement in multiple metrics of episodic memory, but no changes in biomarkers. Improvements in episodic memory were most pronounced in participants who had the highest modeled tACS-induced electric fields and exhibited the greatest changes in RSFC. Increased RSFC was also associated with greater hippocampal excitability and higher baseline white matter integrity. This study highlights initial feasibility and the potential of gamma tACS to rescue episodic memory in an aMCI population by modulating connectivity and excitability within an episodic memory network.
- Published
- 2023
13. Training Response Artificial Intelligence Network (TRAIN)
- Author
-
National Institute on Aging (NIA)
- Published
- 2023
14. Exploring the Relationship between Behavioral and Neurological Impairments Due to Mild Cognitive Impairment: Correlation Study between Virtual Kiosk Test and EEG-SSVEP.
- Author
-
Kim, Dohyun, Kim, Yuwon, Park, Jinseok, Choi, Hojin, Ryu, Hokyoung, Loeser, Martin, and Seo, Kyoungwon
- Subjects
- *
MILD cognitive impairment , *AMNESTIC mild cognitive impairment , *VISUAL evoked potentials , *ACTIVITIES of daily living , *ALZHEIMER'S disease , *MULTIMODAL user interfaces - Abstract
Amnestic mild cognitive impairment (aMCI) is a transitional stage between normal aging and Alzheimer's disease, making early screening imperative for potential intervention and prevention of progression to Alzheimer's disease (AD). Therefore, there is a demand for research to identify effective and easy-to-use tools for aMCI screening. While behavioral tests in virtual reality environments have successfully captured behavioral features related to instrumental activities of daily living for aMCI screening, further investigations are necessary to establish connections between cognitive decline and neurological changes. Utilizing electroencephalography with steady-state visual evoked potentials, this study delved into the correlation between behavioral features recorded during virtual reality tests and neurological features obtained by measuring neural activity in the dorsal stream. As a result, this multimodal approach achieved an impressive screening accuracy of 98.38%. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Episodic memory network characteristics in patients with amnestic mild cognitive impairment accompanied by executive function impairment.
- Author
-
Wang, Chao, Cheng, Rukun, Yang, Wenhao, Qiu, Lin, and Liu, Haifeng
- Subjects
- *
AMNESTIC mild cognitive impairment , *EPISODIC memory , *FUNCTIONAL magnetic resonance imaging , *TEMPORAL lobe , *EXECUTIVE function , *ALZHEIMER'S disease , *CEREBROSPINAL fluid examination , *TAU proteins - Abstract
Objective: To explore the functional connectivity (FC) characteristics of the episodic memory network (EMN) in amnestic mild cognitive impairment (aMCI) patients with different levels of executive function (EF). Methods: This study included 76 participants from the Alzheimer's Disease Neuroimaging Initiative database, comprising 23 healthy controls (HCs) and 53 aMCI patients. Based on EF levels, aMCI patients were categorized into aMCI‐highEF and aMCI‐lowEF groups. Cognitive function scores, pathological markers (cerebrospinal fluid β‐amyloid, total tau protein, phosphorylated tau protein, AV45‐PET, and FDG‐PET), and functional magnetic resonance imaging were collected and compared among the three groups. Seed‐based FC analysis was used to examine differences in the EMN among the groups, and partial correlation analysis was employed to investigate the relationship between changes in FC and cognitive function scores as well as pathological markers. Results: Compared to the aMCI‐highEF group, the aMCI‐lowEF group exhibited more severe cognitive impairment, decreased cerebral glucose metabolism, and elevated AV45 levels. Significant FC differences in the left superior temporal gyrus (STG) of the EMN were observed among the three groups. Post hoc analysis revealed that the aMCI‐lowEF group had increased FC in the left STG compared to the HCs and aMCI‐highEF groups, with statistically significant differences. Correlation analysis showed a significant negative correlation between the differences in FC in the left STG of aMCI‐highEF and aMCI‐lowEF groups and Rey Auditory Verbal Learning Test forgetting scores. Receiver operator characteristic curve analysis indicated an area under the curve of 0.741 for distinguishing between aMCI‐highEF and aMCI‐lowEF groups based on FC of left STG, with a sensitivity of 0.808 and a specificity of 0.667. Conclusion: aMCI‐lowEF exhibits characteristic changes in FC within the EMN, providing theoretical support for the role of EF in mediating EMN alterations and, consequently, impacting episodic memory function. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Visual search for real‐world scenes in patients with Alzheimer's disease and amnestic mild cognitive impairment.
- Author
-
Akkoyun, Müge, Koçoğlu, Koray, Eraslan Boz, Hatice, Tüfekci, Işıl Yağmur, Ekin, Merve, and Akdal, Gülden
- Subjects
- *
EYE tracking , *AMNESTIC mild cognitive impairment , *VISUAL perception , *EYE movements , *ALZHEIMER'S patients , *ALZHEIMER'S disease , *SEARCHING behavior - Abstract
Background: Visual attention‐related processes that underlie visual search behavior are impaired in both the early stages of Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI), which is considered a risk factor for AD. Although traditional computer‐based array tasks have been used to investigate visual search, information on the visual search patterns of AD and MCI patients in real‐world environments is limited. Aim: The objective of this study was to evaluate the differences in visual search behaviors among individuals with AD, aMCI, and healthy controls (HCs) in real‐world scenes. Materials and Methods: A total of 92 participants were enrolled, including 28 with AD, 32 with aMCI, and 32 HCs. During the visual search task, participants were instructed to look at a single target object amid distractors, and their eye movements were recorded. Results: The results indicate that patients with AD made more fixations on distractors and fewer fixations on the target, compared to patients with aMCI and HC groups. Additionally, AD patients had longer fixation durations on distractors and spent less time looking at the target than both patients with aMCI and HCs. Discussion: These findings suggest that visual search behavior is impaired in patients with AD and can be distinguished from aMCI and healthy individuals. For future studies, it is important to longitudinally monitor visual search behavior in the progression from aMCI to AD. Conclusion: Our study holds significance in elucidating the interplay between impairments in attention, visual processes, and other underlying cognitive processes, which contribute to the functional decline observed in individuals with AD and aMCI. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. The Impact of Loneliness in Older Adults Presenting with Memory Impairment: A Single-Center Experience.
- Author
-
Darol, Elif Sarıca and Göger, Seda
- Subjects
LONELINESS ,OLDER people ,AMNESTIC mild cognitive impairment ,MENTAL depression ,LOGISTIC regression analysis - Abstract
Background: Memory impairment may be the first sign of an amnestic mild cognitive impairment (MCI) or geriatric depression. Loneliness hurts consciousness and mood in the elderly population. This study aimed to investigate the impact of loneliness on possible MCI and depressive symptoms in older adults with memory impairment. Method: The data of this cross-sectional study was collected from a single center in Sakarya. Standardized Mini Mental Test (SMMT), geriatric depression, and loneliness scales were applied to 120 older adults who met the inclusion criteria. SPSS 22.0 was used for statistical analysis. Logistic regression analysis were used to determine possible risk factors of MCI and depression. p<0.05 was considered statistically significant. Results: MCI was observed in 41.7%, and geriatric depression in 56.7% of participant. The variables of income level, low education status, loneliness were identified as risk factors for depression (p=0.011, p=0.021, p=0.000 respectively). There was no correlation between the loneliness scores and possible MCI (p=0.173). In addition, age and gender variables are risk factors for mild cognitive impairment, and the risk decreases as age decreases (p=0.004, p=0.033 respectively). Social loneliness scores were higher in women than men (p=0.015). Conclusion: Loneliness in multi-cultural aging population is perceived in different ways between genders. There is no clear evidence that loneliness has a potential impact on MCI. In geriatric depression, social and emotional loneliness; may be considered risk factors. Healthcare providers should consider incorporating depression screening and management into routine care for lonely older adults especially woman subgroup. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Hemispheric asymmetries in hippocampal volume related to memory in left and right temporal variants of frontotemporal degeneration.
- Author
-
Hurley, Robert S., Lapin, Brittany, Jones, Stephen E., Crawford, Anna, Leverenz, James B., Bonner-Jackson, Aaron, and Pillai, Jagan A.
- Subjects
RECOGNITION (Psychology) ,MILD cognitive impairment ,AMNESTIC mild cognitive impairment ,VERBAL memory ,HIPPOCAMPUS (Brain) ,VISUAL memory ,ALZHEIMER'S disease - Abstract
In addition to Alzheimer's disease (AD), the hippocampus is now known to be affected in variants of frontotemporal degeneration (FTD). In semantic variant primary progressive aphasia (svPPA), characterized by language impairments, hippocampal atrophy is greater in the left hemisphere. Nonverbal impairments (e.g., visual object recognition) are prominent in the right temporal variant of FTD (rtvFTD), and hippocampal atrophy may be greater in the right hemisphere. In this study we examined the hypothesis that leftward hippocampal asymmetry (predicted in svPPA) would be associated with selective verbal memory impairments (with relative preservation of visual memory), while rightward asymmetry (predicted in rtvFTD) would be associated with the opposite pattern (greater visual memory impairment). In contrast, we predicted that controls and individuals in the amnestic mild cognitive impairment stage of AD (aMCI), both of whom were expected to show symmetrical hippocampal volumes, would show roughly equivalent scores in verbal and visual memory. Participants completed delayed recall tests with words and geometric shapes, and hippocampal volumes were assessed with MRI. The aMCI sample showed symmetrical hippocampal atrophy, and similar degree of verbal and visual memory impairment. The svPPA sample showed greater left hippocampal atrophy and verbal memory impairment, while rtvFTD showed greater right hippocampal atrophy and visual memory impairment. Greater asymmetry in hippocampal volumes was associated with larger differences between verbal and visual memory in the FTD samples. Unlike AD, asymmetry is a core feature of brain-memory relationships in temporal variants of FTD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Patterns of longitudinal subcortical atrophy over one year in amnestic mild cognitive impairment and its impact on cognitive performance: a preliminary study.
- Author
-
ÇAVUŞOĞLU, Berrin, HÜNERLİ, Duygu, EMEK SAVAŞ, Derya Durusu, YENER, Görsev, and ADA, Emel
- Subjects
- *
AMNESTIC mild cognitive impairment , *MILD cognitive impairment , *COGNITIVE ability , *GLOBUS pallidus , *NUCLEUS accumbens , *CEREBRAL atrophy - Abstract
Background/aim: Amnestic mild cognitive impairment (aMCI) is a risk factor for dementia, and thus, it is of interest to enlighten specific brain atrophy patterns in aMCI patients. We aim to define the longitudinal atrophy pattern in subcortical structures and its effect on cognition in patients with aMCI. Materials and methods: Twenty patients with aMCI and 20 demographically matched healthy controls with baseline and longitudinal structural magnetic resonance imaging scans and neuropsychological assessments were studied. The algorithm FIRST (FMRIB’s integrated registration and segmentation tool) was used to obtain volumes of subcortical structures (thalamus, putamen, caudate nucleus, nucleus accumbens, globus pallidus, hippocampus, and amygdala). Correlations between volumes and cognitive performance were assessed. Results: Compared with healthy controls, aMCI demonstrated subcortical atrophies in the hippocampus (p = 0.001), nucleus accumbens (p = 0.003), and thalamus (p = 0.003) at baseline. Significant associations were found for the baseline volumes of the thalamus, nucleus accumbens, and hippocampus with memory, the thalamus with visuospatial skills. Conclusion: aMCI demonstrated subcortical atrophies associated with cognitive deficits. The thalamus, nucleus accumbens, and hippocampus may provide additional diagnostic information for aMCI. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Neuroticism polygenic risk predicts conversion from mild cognitive impairment to Alzheimer's disease by impairing inferior parietal surface area.
- Author
-
Li, Qiaojun, Lv, Xingping, Qian, Qian, Liao, Kun, and Du, Xin
- Subjects
- *
MILD cognitive impairment , *ALZHEIMER'S disease , *GENETIC risk score , *MONOGENIC & polygenic inheritance (Genetics) , *AMNESTIC mild cognitive impairment , *NEUROTICISM - Abstract
The high prevalence of conversion from amnestic mild cognitive impairment (aMCI) to Alzheimer's disease (AD) makes early prevention of AD extremely critical. Neuroticism, a heritable personality trait associated with mental health, has been considered a risk factor for conversion from aMCI to AD. However, whether the neuroticism genetic risk could predict the conversion of aMCI and its underlying neural mechanisms is unclear. Neuroticism polygenic risk score (N‐PRS) was calculated in 278 aMCI patients with qualified genomic and neuroimaging data from ADNI. After 1‐year follow‐up, N‐PRS in patients of aMCI‐converted group was significantly greater than those in aMCI‐stable group. Logistic and Cox survival regression revealed that N‐PRS could significantly predict the early‐stage conversion risk from aMCI to AD. These results were well replicated in an internal dataset and an independent external dataset of 933 aMCI patients from the UK Biobank. One sample Mendelian randomization analyses confirmed a potentially causal association from higher N‐PRS to lower inferior parietal surface area to higher conversion risk of aMCI patients. These analyses indicated that neuroticism genetic risk may increase the conversion risk from aMCI to AD by impairing the inferior parietal structure. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. The diagnostic and prognostic value of tau‐PET in amnestic MCI with different FDG‐PET subtypes.
- Author
-
Boccalini, Cecilia, Caminiti, Silvia Paola, Chiti, Arturo, Frisoni, Giovanni B., Garibotto, Valentina, and Perani, Daniela
- Subjects
- *
AMNESTIC mild cognitive impairment , *PROGNOSIS ,BRAIN metabolism - Abstract
Objectives: Mild cognitive impairment presenting with an amnestic syndrome (aMCI) and amyloid positivity is considered due to AD. Many subjects, however, can show an overall very slow progression relevant for differential diagnosis, prognosis, and treatment. This study assessed PET biomarkers, including brain glucose metabolism, tau, and amyloid load, in a series of comparable aMCI at baseline, clinically evaluated at follow‐up. Methods: We included 72 aMCI subjects from Geneva Memory Center (N = 31) and ADNI cohorts (N = 41), selected based on available FDG‐PET, tau‐PET, amyloid‐PET, and clinical follow‐up (2.3 years ± 1.2). A data‐driven algorithm classified brain metabolic patterns into subtypes that were then compared for clinical and PET biomarker measures and cognitive decline. Voxel‐wise comparisons were performed both with FDG‐PET and tau‐PET data. Results: The algorithm classified three metabolic subtypes, namely "Hippocampal‐sparing with cortical hypometabolism" (Type1; N = 27), "Hippocampal and cortical hypometabolism" (Type 2; N = 23), and "Medial temporal hypometabolism" (Type 3; N = 22). Amyloid positivity and tau accumulation in the medial temporal and neocortical regions characterized Type 1 and Type 2, whereas Type 3 showed no significant tau pathology, variable amyloid positivity, and stability at follow‐up. All tau‐positive patients, independently of the FDG‐based subtype, showed faster cognitive decline. Interpretation: aMCI subjects can differ in metabolic patterns, tau and amyloid pathology, and clinical progression. Here, we complemented with PET tau biomarker the specific brain hypometabolic patterns at the individual level in the prodromal phase, contributing to the patient's classification. Tau PET is the most accurate biomarker in supporting or excluding the AD diagnosis in aMCI across metabolic subtypes and also predicting the risk of decline. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Combining neuropsychological assessment and structural neuroimaging to identify early Alzheimer's disease in a memory clinic cohort.
- Author
-
Quek, Yi‐En, Fung, Yi Leng, Bourgeat, Pierrick, Vogrin, Simon J., Collins, Steven J., and Bowden, Stephen C.
- Subjects
- *
ALZHEIMER'S disease , *ENTORHINAL cortex , *NEUROPSYCHOLOGICAL tests , *AMNESTIC mild cognitive impairment , *MAGNETIC resonance imaging , *CLINICS , *VOLUME measurements - Abstract
Introduction: The current study examined the contributions of comprehensive neuropsychological assessment and volumetric assessment of selected mesial temporal subregions on structural magnetic resonance imaging (MRI) to identify patients with amnestic mild cognitive impairment (aMCI) and mild probable Alzheimer's disease (AD) dementia in a memory clinic cohort. Methods: Comprehensive neuropsychological assessment and automated entorhinal, transentorhinal, and hippocampal volume measurements were conducted in 40 healthy controls, 38 patients with subjective memory symptoms, 16 patients with aMCI, 16 patients with mild probable AD dementia. Multinomial logistic regression was used to compare the neuropsychological and MRI measures. Results: Combining the neuropsychological and MRI measures improved group membership prediction over the MRI measures alone but did not improve group membership prediction over the neuropsychological measures alone. Conclusion: Comprehensive neuropsychological assessment was an important tool to evaluate cognitive impairment. The mesial temporal volumetric MRI measures contributed no diagnostic value over and above the determinations made through neuropsychological assessment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Hyperbaric Oxygen Improves Long-Term Learning and Memory Impairment by Attenuating Neuronal Apoptosis in aMCI Rats.
- Author
-
Zhang, Yonggui, Lin, Xianzhong, Ye, Chen, and Zhang, Peiling
- Subjects
LONG-term memory ,MEMORY disorders ,AMNESTIC mild cognitive impairment ,DEATH receptors ,NEURONS - Abstract
Background: With the aging of the population and the increasing incidence of neurological diseases, amnestic mild cognitive impairment (aMCI) has attracted attention. Hyperbaric oxygen (HBO) has gradually shown the potential in the treatment of aMCI as an emerging treatment method in recent times. This study is to observe the effect of HBO on the long-term learning memory of aMCI rats, and investigate the associated mechanisms. Methods: Seventy-two male rats (4-month-old) were randomly divided into control (CON) group, aMCI group, HBO group, 24 rats in each group. Each group was randomly divided into CON
1 , CON7 , CON28 ; aMCI1 , aMCI7 , aMCI28 ; HBO1 , HBO7 , HBO28 , 8 rats in each group. The aMCI model rats were established in aMCI and HBO groups. HBO group was treated with HBO for 7 days. The ethological and cytopathology which include Morris water maze (MWM) test, HE staining, TUNEL staining and the expression of Fas/FasL on neuron membrane were conducted to evaluate the effects of HBO on day 1, day 7 and day 28 after HBO treatment. Results: MWM test showed that the spatial learning and memory ability of the rats decreased in aMCI group, and recovered in HBO group; Compared with aMCI group, the pathological damage of hippocampal nerve cells was alleviated, the number of apoptotic cells was significantly reduced (P < 0.05), and the expression of Fas/FasL on the surface of nerve cell membrane was significantly weakened in HBO group (P < 0.05). There were no significant changes in the spatial learning and memory ability, pathological damage of hippocampal neurons, the number of apoptotic cells, and the changes of Fas/FasL on the surface of hippocampal neurons in HBO1 , HBO7 , and HBO28 groups (P > 0.05). However, in aMCI1, aMCI7 , and aMCI28 groups gradually aggravated (P < 0.05). Conclusion: 1. HBO can improve the long-term learning and memory impairment by attenuating neuronal apoptosis in aMCI rats. 2. Fas/FasL mediated cell receptor death pathway is involved in the apoptosis of hippocampal neurons. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
24. Associations of apolipoprotein E ε4 allele, regional cerebral blood flow, and serum liver function markers in patients with cognitive impairment.
- Author
-
Hao Wang, Lin Shi, Shimei Luo, Yishan Luo, Chunyan Xu, Guozhen Qiu, Qiwen Guo, Chunchun Chen, Taikun Lu, Kangding Liu, and Feiqi Zhu
- Subjects
CEREBRAL circulation ,APOLIPOPROTEIN E ,AMNESTIC mild cognitive impairment ,SPIN labels ,COGNITION disorders ,MILD cognitive impairment - Abstract
Introduction: The ε4 allele of the apolipoprotein E gene (APOE4) is expressed abundantly in both the brain and peripheral circulation as a genetic risk factor for Alzheimer's disease (AD). Cerebral blood flow (CBF) dysfunction is an essential feature of AD, and the liver plays an important role in the pathogenesis of dementia. However, the associations of APOE4 with CBF and liver function markers in patients with cognitive impairment remains unclear. We aimed to evaluate the associations of APOE4 with CBF measured by arterial spin labeling (ASL) magnetic resonance imaging (MRI) and serum liver function markers in participants who were diagnosed with cognitive impairment. Methods: Fourteen participants with AD and sixteen with amnestic mild cognitive impairment (MCI) were recruited. In addition to providing comprehensive clinical information, all patients underwent laboratory tests and MRI. All participants were divided into carriers and noncarriers of the ε4 allele, and T-tests and Mann--Whitney U tests were used to observe the differences between APOE4 carriers and noncarriers in CBF and liver function markers. Results: Regarding regional cerebral blood flow (rCBF), APOE4 carriers showed hyperperfusion in the bilateral occipital cortex, bilateral thalamus, and left precuneus and hypoperfusion in the right lateral temporal cortex when compared with noncarriers. Regarding serum liver function markers, bilirubin levels (including total, direct, and indirect) were lower in APOE4 carriers than in noncarriers. Conclusion: APOE4 exerts a strong effect on CBF dysfunction by inheritance, representing a risk factor for AD. APOE4 may be related to bilirubin metabolism, potentially providing specific neural targets for the diagnosis and treatment of AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Frequency-dependent alterations in functional connectivity in patients with Alzheimer's Disease spectrum disorders.
- Author
-
Hanjun Hu, Luoyu Wang, Abdul, Sammad, Xue Tang, Qi Feng, Yuzhu Mu, Xiuhong Ge, Zhengluan Liao, and Zhongxiang Ding
- Subjects
BRAIN physiology ,PEARSON correlation (Statistics) ,FUNCTIONAL connectivity ,ALZHEIMER'S disease ,MILD cognitive impairment ,DATA analysis ,T-test (Statistics) ,RESEARCH funding ,FUNCTIONAL assessment ,MAGNETIC resonance imaging ,ANALYSIS of variance ,STATISTICS ,NEUROPSYCHOLOGICAL tests ,DATA analysis software - Abstract
Background: In the spectrum of Alzheimer's Disease (AD) and related disorders, the resting-state functional magnetic resonance imaging (rs-fMRI) signals within the cerebral cortex may exhibit distinct characteristics across various frequency ranges. Nevertheless, this hypothesis has not yet been substantiated within the broader context of whole-brain functional connectivity. This study aims to explore potential modifications in degree centrality (DC) and voxelmirrored homotopic connectivity (VMHC) among individuals with amnestic mild cognitive impairment (aMCI) and AD, while assessing whether these alterations differ across distinct frequency bands. Methods: This investigation encompassed a total of 53 AD patients, 40 aMCI patients, and 40 healthy controls (HCs). DC and VMHC values were computed within three distinct frequency bands: classical (0.01-0.08 Hz), slow-4 (0.027-0.073 Hz), and slow-5 (0.01-0.027 Hz) for the three respective groups. To discern differences among these groups, ANOVA and subsequent post hoc two-sample t-tests were employed. Cognitive function assessment utilized the mini-mental state examination (MMSE) and Montreal Cognitive Assessment (MoCA). Pearson correlation analysis was applied to investigate the associations between MMSE and MoCA scores with DC and VMHC. Results: Significant variations in degree centrality (DC) were observed among different groups across diverse frequency bands. The most notable differences were identified in the bilateral caudate nucleus (CN), bilateral medial superior frontal gyrus (mSFG), bilateral Lobule VIII of the cerebellar hemisphere (Lobule VIII), left precuneus (PCu), right Lobule VI of the cerebellar hemisphere (Lobule VI), and right Lobule IV and V of the cerebellar hemisphere (Lobule IV, V). Likewise, disparities in voxel-mirrored homotopic connectivity (VMHC) among groups were predominantly localized to the posterior cingulate gyrus (PCG) and Crus II of the cerebellar hemisphere (Crus II). Across the three frequency bands, the brain regions exhibiting significant differences in various parameters were most abundant in the slow-5 frequency band. Conclusion: This study enhances our understanding of the pathological and physiological mechanisms associated with AD continuum. Moreover, it underscores the importance of researchers considering various frequency bands in their investigations of brain function. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Neuroimaging-guided diagnosis of possible FTLD-FUS pathology: a case report.
- Author
-
Mathoux, Gregory, Boccalini, Cecilia, Lathuliere, Aurelien, Scheffler, Max, Frisoni, Giovanni B., and Garibotto, Valentina
- Subjects
- *
CEREBROSPINAL fluid examination , *AMNESTIC mild cognitive impairment , *PATHOLOGY , *ALZHEIMER'S disease , *NEUROPSYCHOLOGICAL tests , *DIAGNOSIS - Abstract
Background: This case report presents a patient with progressive memory loss and choreiform movements. Case presentation: Neuropsychological tests indicated multi-domain amnestic mild cognitive impairment (aMCI), and neurological examination revealed asymmetrical involuntary hyperkinetic movements. Imaging studies showed severe left-sided atrophy and hypometabolism in the left frontal and temporoparietal cortex. [18F]Flortaucipir PET exhibited moderately increased tracer uptake in hypometabolic areas. The diagnosis initially considered Alzheimer's disease (AD), frontotemporal degeneration (FTD), and corticobasal degeneration (CBD), cerebral hemiatrophy syndrome, but imaging and cerebrospinal fluid analysis excluded AD and suggested fused-in-sarcoma-associated FTD (FTLD-FUS), a subtype of the behavioural variant of FTD. Conclusions: Our case highlights that despite the lack of specific FUS biomarkers the combination of clinical features and neuroimaging biomarkers can guide choosing the most likely differential diagnosis in a complex neurological case. Imaging in particular allowed an accurate measure of the topography and severity of neurodegeneration and the exclusion of AD-related pathology. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Multiparametric hippocampal signatures for early diagnosis of Alzheimer's disease using 18F‐FDG PET/MRI Radiomics.
- Author
-
Chen, Zhigeng, Bi, Sheng, Shan, Yi, Cui, Bixiao, Yang, Hongwei, Qi, Zhigang, Zhao, Zhilian, Han, Ying, Yan, Shaozhen, and Lu, Jie
- Subjects
- *
ALZHEIMER'S disease , *RADIOMICS , *AMNESTIC mild cognitive impairment , *EARLY diagnosis , *RECEIVER operating characteristic curves - Abstract
Purpose: This study aimed to explore the utility of hippocampal radiomics using multiparametric simultaneous positron emission tomography (PET)/magnetic resonance imaging (MRI) for early diagnosis of Alzheimer's disease (AD). Methods: A total of 53 healthy control (HC) participants, 55 patients with amnestic mild cognitive impairment (aMCI), and 51 patients with AD were included in this study. All participants accepted simultaneous PET/MRI scans, including 18F‐fluorodeoxyglucose (18F‐FDG) PET, 3D arterial spin labeling (ASL), and high‐resolution T1‐weighted imaging (3D T1WI). Radiomics features were extracted from the hippocampus region on those three modal images. Logistic regression models were trained to classify AD and HC, AD and aMCI, aMCI and HC respectively. The diagnostic performance and radiomics score (Rad‐Score) of logistic regression models were evaluated from 5‐fold cross‐validation. Results: The hippocampal radiomics features demonstrated favorable diagnostic performance, with the multimodal classifier outperforming the single‐modal classifier in the binary classification of HC, aMCI, and AD. Using the multimodal classifier, we achieved an area under the receiver operating characteristic curve (AUC) of 0.98 and accuracy of 96.7% for classifying AD from HC, and an AUC of 0.86 and accuracy of 80.6% for classifying aMCI from HC. The value of Rad‐Score differed significantly between the AD and HC (p < 0.001), aMCI and HC (p < 0.001) groups. Decision curve analysis showed superior clinical benefits of multimodal classifiers compared to neuropsychological tests. Conclusion: Multiparametric hippocampal radiomics using PET/MRI aids in the identification of early AD, and may provide a potential biomarker for clinical applications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Greater white matter degeneration and lower structural connectivity in non-amnestic vs. amnestic Alzheimer's disease.
- Author
-
Phillips, Jeffrey S., Adluru, Nagesh, Chung, Moo K., Radhakrishnan, Hamsanandini, Olm, Christopher A., Cook, Philip A., Gee, James C., Cousins, Katheryn A. Q., Arezoumandan, Sanaz, Wolk, David A., McMillan, Corey T., Grossman, Murray, and Irwin, David J.
- Subjects
ALZHEIMER'S disease ,FRONTOTEMPORAL lobar degeneration ,WHITE matter (Nerve tissue) ,AMNESTIC mild cognitive impairment ,CEREBRAL atrophy ,DIFFUSION magnetic resonance imaging - Abstract
Introduction: Multimodal evidence indicates Alzheimer's disease (AD) is characterized by early white matter (WM) changes that precede overt cognitive impairment. WM changes have overwhelmingly been investigated in typical, amnestic mild cognitive impairment and AD; fewer studies have addressed WM change in atypical, non-amnestic syndromes. We hypothesized each nonamnestic AD syndrome would exhibit WM differences from amnestic and other non-amnestic syndromes. Materials and methods: Participants included 45 cognitively normal (CN) individuals; 41 amnestic AD patients; and 67 patients with non-amnestic AD syndromes including logopenic-variant primary progressive aphasia (lvPPA, n = 32), posterior cortical atrophy (PCA, n = 17), behavioral variant AD (bvAD, n = 10), and corticobasal syndrome (CBS, n = 8). All had T1-weighted MRI and 30-direction diffusion-weighted imaging (DWI). We performed whole-brain deterministic tractography between 148 cortical and subcortical regions; connection strength was quantified by tractwise mean generalized fractional anisotropy. Regression models assessed effects of group and phenotype as well as associations with grey matter volume. Topological analyses assessed differences in persistent homology (numbers of graph components and cycles). Additionally, we tested associations of topological metrics with global cognition, disease duration, and DWI microstructural metrics. Results: Both amnestic and non-amnestic patients exhibited lower WM connection strength than CN participants in corpus callosum, cingulum, and inferior and superior longitudinal fasciculi. Overall, non-amnestic patients had more WM disease than amnestic patients. LvPPA patients had left-lateralized WM degeneration; PCA patients had reductions in connections to bilateral posterior parietal, occipital, and temporal areas. Topological analysis showed the nonamnestic but not the amnestic group had more connected components than controls, indicating persistently lower connectivity. Longer disease duration and cognitive impairment were associated with more connected components and fewer cycles in individuals' brain graphs. Discussion: We have previously reported syndromic differences in GM degeneration and tau accumulation between AD syndromes; here we find corresponding differences in WM tracts connecting syndrome-specific epicenters. Determining the reasons for selective WM degeneration in nonamnestic AD is a research priority that will require integration of knowledge from neuroimaging, biomarker, autopsy, and functional genetic studies. Furthermore, longitudinal studies to determine the chronology of WM vs. GM degeneration will be key to assessing evidence for WM-mediated tau spread. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Reversal of the concreteness effect can be detected in the natural speech of older adults with amnestic, but not non‐amnestic, mild cognitive impairment.
- Author
-
Cao, Luwen, Han, Kunmei, Lin, Li, Hing, Jiawen, Ooi, Vincent, Huang, Nick, Yu, Junhong, Ng, Ted Kheng Siang, Feng, Lei, Mahendran, Rathi, Kua, Ee Heok, and Bao, Zhiming
- Subjects
MILD cognitive impairment ,VERBS ,SPEECH ,AMNESTIC mild cognitive impairment ,OLDER people ,ALZHEIMER'S patients ,SPEECH apraxia - Abstract
INTRODUCTION: Patients with Alzheimer's disease present with difficulty in lexical retrieval and reversal of the concreteness effect in nouns. Little is known about the phenomena before the onset of symptoms. We anticipate early linguistic signs in the speech of people who suffer from amnestic mild cognitive impairment (MCI). Here, we report the results of a corpus‐linguistic approach to the early detection of cognitive impairment. METHODS: One hundred forty‐eight English‐speaking Singaporeans provided natural speech data, on topics of their choice; 74 were diagnosed with single‐domain MCI (38 amnestic, 36 non‐amnestic), 74 cognitively healthy. The recordings yield 267,310 words, which are tagged for parts of speech. We calculate the per‐minute word counts and concreteness scores of all tagged words, nouns, and verbs in the dataset. RESULTS: Compared to controls, subjects with amnestic MCI produce fewer but more abstract nouns. Verbs are not affected. DISCUSSION: Slower retrieval of nouns and the reversal of the concreteness effect in nouns are manifested in natural speech and can be detected early through corpus‐based analysis. Highlights: Reversal of the concreteness effect is manifested in patients with Alzheimer's disease (AD) and semantic dementia.The paper reports a corpus‐based analysis of natural speech by people with amnestic and non‐amnestic mild cognitive impairment (MCI) and cognitively healthy controls.People with amnestic MCI produce fewer and more abstract nouns than people with non‐amnestic MCI and healthy controls. Verbs appear to be unaffected.The imageability problem can be detected in natural everyday speech by people with amnestic MCI, which carries a higher risk of conversion to AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Effect of polycyclic aromatic hydrocarbon exposure on amnestic mild cognitive impairment and Alzheimer’s disease: A matched case-control study
- Author
-
Heeseon Jang, Jungwoo Sohn, Hee Jin Kim, Sang Won Seo, Young Noh, Sang-Baek Koh, Jaelim Cho, and Changsoo Kim
- Subjects
Polycyclic aromatic hydrocarbons ,Environmental pollution ,Neurodegenerative diseases ,Amnestic mild cognitive impairment ,Alzheimer’s disease ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
There is an emerging body of evidence concerning the neurological effect of air pollutants on cognitive function and increased risk of neurodegeneration. Although previous studies have suggested that polycyclic aromatic hydrocarbons (PAHs) are neurotoxic, the effect of PAHs exposure on neurodegeneration remains unclear. This study aimed to investigate the association between PAH exposure and the risk of developing amnestic mild cognitive impairment (aMCI) and Alzheimer’s disease (AD). For this matched case-control cross-sectional study, we recruited patients aged ≥50 years diagnosed with aMCI and AD from the Samsung Medical Center, Seoul, Korea, between 2014 and 2019. For each patient, we randomly selected four cognitively healthy controls through frequency matching based on sex, age group, and education level. Urinary levels of four PAH metabolites, 1-hydroxypyrene (1-OHP), 1-hydroxyphenanthrene (1-OHPhe), 2-hydroxyfluorene (2-OHFlu), and 2-naphthol (2-NAP), were measured. A conditional logistic regression model was used to evaluate the association, adjusting for potential confounders. A total of 212 patients with aMCI with 848 matched controls, and 267 patients with AD with 1068 matched controls were included in the analyses to estimate the risk of PAH exposure. We found that elevated urinary levels of PAH metabolites (specifically, 1-OHP and 2-NAP) were significantly associated with an increased risk of aMCI and AD. An increase of one unit in log-transformed level of urinary 1-OHP was associated with a 1.15- and 1.16-times higher risk of aMCI and AD, respectively. An increase of one unit in log-transformed level of urinary 2-NAP was associated with a 1.11- and 1.13-times higher risk of aMCI and AD, respectively. These findings indicate that PAH exposure may increase the risk of aMCI and AD, especially for the elderly population. Considering the widespread distribution of PAHs in the environment, reducing PAH exposure may be an effective strategy for the prevention of neurodegenerative diseases.
- Published
- 2024
- Full Text
- View/download PDF
31. Tongue coating-dependent superior temporal sulcus remodeling in amnestic mild cognitive impairment
- Author
-
Juan-Juan Lu, Jie Ma, Jia-Jia Wu, Xiao-Min Zhen, Yun-Ting Xiang, Hao-Yu Lu, Mou-Xiong Zheng, Xu-Yun Hua, and Jian-Guang Xu
- Subjects
Amnestic mild cognitive impairment ,Multi-modal MRI ,Tongue coating ,Superior temporal sulcus ,Cognitive function ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Tongue coating affects cognition, and cognitive decline at early stage also showed relations to functional and structural remodeling of superior temporal sulcus (STS) in amnestic mild cognitive impairment (aMCI). The potential correlation between disparate cognitive manifestations in aMCI patients with different tongue coatings, and corresponding mechanisms of STS remodeling remains uncharted. In this case-control study, aMCI patients were divided into thin coating (n = 18) and thick coating (n = 21) groups. All participants underwent neuropsychological evaluations and multimodal magnetic resonance imaging. Group comparisons were conducted in clinical assessments and neuroimaging measures of banks of the STS (bankssts). Generalized linear models were constructed to explore relationships between neuroimaging measures and cognition. aMCI patients in the thick coating group exhibited significantly poorer immediate and delayed recall and slower information processing speed (IPS) (P < 0.05), and decreased functional connectivity (FC) of bilateral bankssts with frontoparietal cortices (P < 0.05, AlphaSim corrected) compared to the thin coating group. It was found notable correlations between cognition encompassing recall and IPS, and FC of bilateral bankssts with frontoparietal cortices (P < 0.05, Bonferroni's correction), as well as interaction effects of group × regional homogeneity (ReHo) of right bankssts on the first immediate recall (P < 0.05, Bonferroni's correction). aMCI patients with thick coating exhibited poor cognitive performance, which might be attributed to decreased FC seeding from bankssts. Our findings strengthen the understanding of brain reorganization of STS via which tongue coating status impacts cognition in patients with aMCI.
- Published
- 2024
- Full Text
- View/download PDF
32. Editorial: The cognitive neuroscience of aging: where we are and where we are going.
- Author
-
Uquillas, Federico d'Oleire, Falck, Ryan S., and Oken, Barry S.
- Subjects
BEHAVIORAL neuroscience ,COGNITIVE aging ,COGNITIVE neuroscience ,DISEASE risk factors ,AMNESTIC mild cognitive impairment - Published
- 2024
- Full Text
- View/download PDF
33. mSIM: Mobile Simultaneous Aerobic Exercise and Memory Training Intervention for Amnestic Mild Cognitive Impairment (mSIM)
- Author
-
National Institutes of Health (NIH), National Institute on Aging (NIA), and Jennifer Bramen, Assistant Professor
- Published
- 2023
34. COG-REAGENT: COGnitive tRaining in patiEnts With Amnestic Mild coGnitive impairmENT
- Author
-
The First Affiliated Hospital of Shanxi Medical University, Shandong Provincial Hospital, First Affiliated Hospital of Zhejiang University, The First Hospital of Jilin University, Beijing Friendship Hospital, First Affiliated Hospital Xi'an Jiaotong University, and Wuhan University
- Published
- 2023
35. Electroencephalography-based classification of Alzheimer’s disease spectrum during computer-based cognitive testing
- Author
-
Seul-Kee Kim, Hayom Kim, Sang Hee Kim, Jung Bin Kim, and Laehyun Kim
- Subjects
Alzheimer’s disease ,Mild cognitive impairment ,Subjective cognitive decline ,Non-amnestic mild cognitive impairment ,Amnestic mild cognitive impairment ,Memory-encoding states ,Medicine ,Science - Abstract
Abstract Alzheimer’s disease (AD) is a progressive disease leading to cognitive decline, and to prevent it, researchers seek to diagnose mild cognitive impairment (MCI) early. Particularly, non-amnestic MCI (naMCI) is often mistaken for normal aging as the representative symptom of AD, memory decline, is absent. Subjective cognitive decline (SCD), an intermediate step between normal aging and MCI, is crucial for prediction or early detection of MCI, which determines the presence of AD spectrum pathology. We developed a computer-based cognitive task to classify the presence or absence of AD pathology and stage within the AD spectrum, and attempted to perform multi-stage classification through electroencephalography (EEG) during resting and memory encoding state. The resting and memory-encoding states of 58 patients (20 with SCD, 10 with naMCI, 18 with aMCI, and 10 with AD) were measured and classified into four groups. We extracted features that could reflect the phase, spectral, and temporal characteristics of the resting and memory-encoding states. For the classification, we compared nine machine learning models and three deep learning models using Leave-one-subject-out strategy. Significant correlations were found between the existing neurophysiological test scores and performance of our computer-based cognitive task for all cognitive domains. In all models used, the memory-encoding states realized a higher classification performance than resting states. The best model for the 4-class classification was cKNN. The highest accuracy using resting state data was 67.24%, while it was 93.10% using memory encoding state data. This study involving participants with SCD, naMCI, aMCI, and AD focused on early Alzheimer’s diagnosis. The research used EEG data during resting and memory encoding states to classify these groups, demonstrating the significance of cognitive process-related brain waves for diagnosis. The computer-based cognitive task introduced in the study offers a time-efficient alternative to traditional neuropsychological tests, showing a strong correlation with their results and serving as a valuable tool to assess cognitive impairment with reduced bias.
- Published
- 2024
- Full Text
- View/download PDF
36. Electroencephalography-based classification of Alzheimer's disease spectrum during computer-based cognitive testing.
- Author
-
Kim, Seul-Kee, Kim, Hayom, Kim, Sang Hee, Kim, Jung Bin, and Kim, Laehyun
- Subjects
- *
ALZHEIMER'S disease , *DEEP learning , *COGNITIVE testing , *MACHINE learning , *MILD cognitive impairment , *BRAIN waves - Abstract
Alzheimer's disease (AD) is a progressive disease leading to cognitive decline, and to prevent it, researchers seek to diagnose mild cognitive impairment (MCI) early. Particularly, non-amnestic MCI (naMCI) is often mistaken for normal aging as the representative symptom of AD, memory decline, is absent. Subjective cognitive decline (SCD), an intermediate step between normal aging and MCI, is crucial for prediction or early detection of MCI, which determines the presence of AD spectrum pathology. We developed a computer-based cognitive task to classify the presence or absence of AD pathology and stage within the AD spectrum, and attempted to perform multi-stage classification through electroencephalography (EEG) during resting and memory encoding state. The resting and memory-encoding states of 58 patients (20 with SCD, 10 with naMCI, 18 with aMCI, and 10 with AD) were measured and classified into four groups. We extracted features that could reflect the phase, spectral, and temporal characteristics of the resting and memory-encoding states. For the classification, we compared nine machine learning models and three deep learning models using Leave-one-subject-out strategy. Significant correlations were found between the existing neurophysiological test scores and performance of our computer-based cognitive task for all cognitive domains. In all models used, the memory-encoding states realized a higher classification performance than resting states. The best model for the 4-class classification was cKNN. The highest accuracy using resting state data was 67.24%, while it was 93.10% using memory encoding state data. This study involving participants with SCD, naMCI, aMCI, and AD focused on early Alzheimer's diagnosis. The research used EEG data during resting and memory encoding states to classify these groups, demonstrating the significance of cognitive process-related brain waves for diagnosis. The computer-based cognitive task introduced in the study offers a time-efficient alternative to traditional neuropsychological tests, showing a strong correlation with their results and serving as a valuable tool to assess cognitive impairment with reduced bias. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial.
- Author
-
Possemis, Nina, Verhey, Frans, Prickaerts, Jos, Blokland, Arjan, and Ramakers, Inez
- Subjects
- *
MILD cognitive impairment , *ALZHEIMER'S disease , *AMNESTIC mild cognitive impairment , *PROOF of concept , *RESEARCH protocols , *PREMATURE infants , *NURSING home patients - Abstract
Background: Research into the neurobiological underpinnings of learning and memory has demonstrated the cognitive-enhancing effects associated with diverse classes of phosphodiesterase (PDE) inhibitors. Specific PDE inhibitors have been identified to improve neuronal communication through selective inhibition of PDE activity. Roflumilast, a PDE4 inhibitor, has demonstrated efficacy in enhancing episodic memory in healthy adults and elderly participants with pronounced memory impairment, indicative of amnestic mild cognitive impairment (aMCI). In alignment with these findings, the present protocol aims to provide a proof of concept phase II of the potential of roflumilast to aid patients diagnosed with (a)MCI or mild Alzheimer's disease (AD) dementia. Methods: The study will be conducted according to a double-blind, randomized placebo-controlled, between-subjects design. Participants with (a)MCI and mild AD dementia will be recruited through the Memory Clinic at the Maastricht University Medical Centre + (MUMC +) in Maastricht, the Netherlands, alongside outreach through regional hospitals, and social media. The study will have three arms: placebo, 50 μg roflumilast, and 100 μg roflumilast, with a treatment duration of 24 weeks. The primary outcome measure will focus on the assessment of episodic memory, as evaluated through participants' performance on the 15-word Verbal Learning Task (VLT). Our secondary objectives are multifaceted, including an exploration of various cognitive domains. In addition, insights into the well-being and daily functioning of participants will be investigated through interviews with both the participants and their (informal) caregivers, we are interested in the well-being and daily functioning of the participants. Discussion: The outcomes of the present study aim to elucidate the significance of the PDE4 inhibition mechanism as a prospective therapeutic target for enhancing cognitive function in individuals with (a)MCI and mild AD dementia. Identifying positive effects within these patient cohorts could extend the relevance of this treatment to encompass a broader spectrum of neurological disorders. Trial registration: The Medical Ethics Committee of MUMC + granted ethics approval for the 4th version of the protocol on September 10th, 2020. The trial was registered at the European Drug Regulatory Affairs Clinical Trials (EudraCT) registered on the 19th of December 2019 (https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-004959-36/NL) and ClinicalTrial.gov (NCT04658654, https://clinicaltrials.gov/study/NCT04658654?intr=roflumilast&cond=mci&rank=1) on the 8th of December 2020. The Central Committee on Research Involving Human Subjects (CCMO) granted approval on the 30th of September 2020. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Lost in space(s): Multimodal neuroimaging of disorientation along the Alzheimer's disease continuum.
- Author
-
Peters‐Founshtein, Gregory, Gazit, Lidor, Naveh, Tahel, Domachevsky, Liran, Korczyn, Amos D., Bernstine, Hanna, Shaharabani‐Gargir, Limor, Groshar, David, Marshall, Gad A., and Arzy, Shahar
- Subjects
- *
MILD cognitive impairment , *ALZHEIMER'S disease , *AMNESTIC mild cognitive impairment , *DEFAULT mode network , *NEUROLOGIC examination , *CEREBRAL atrophy , *CEREBRAL amyloid angiopathy - Abstract
Orientation is a fundamental cognitive faculty and the bedrock of the neurologic examination. Orientation is defined as the alignment between an individual's internal representation and the external world in the spatial, temporal, and social domains. While spatial disorientation is a recognized hallmark of Alzheimer's disease (AD), little is known about disorientation beyond space in AD. This study aimed to explore disorientation in spatial, temporal, and social domains along the AD continuum. Fifty‐one participants along the AD continuum performed an ecological orientation task in the spatial, temporal, and social domains while undergoing functional MRI. Disorientation in AD followed a three‐way association between orientation domain, brain region, and disease stage. Specifically, patients with early amnestic mild cognitive impairment exhibited spatio‐temporal disorientation and reduced brain activity in temporoparietal regions, while patients with AD dementia showed additional social disorientation and reduced brain activity in frontoparietal regions. Furthermore, patterns of hypoactivation overlapped different subnetworks of the default mode network, patterns of fluorodeoxyglucose hypometabolism, and cortical atrophy characteristic of AD. Our results suggest that AD may encompass a disorder of orientation, characterized by a biphasic process manifesting as early spatio‐temporal and late social disorientation. As such, disorientation may offer a unique window into the clinicopathological progression of AD. Significance statement: Despite extensive research into Alzheimer's disease (AD), its core cognitive deficit remains a matter of debate. In this study, we investigated whether orientation, defined as the ability to align internal representations with the external world in spatial, temporal, and social domains, constitutes a core cognitive deficit in AD. To do so, we used PET‐fMRI imaging to collect behavioral, functional, and metabolic data from 51 participants along the AD continuum. Our findings suggest that AD may constitute a disorder of orientation, characterized by an early spatio‐temporal disorientation and followed by late social disorientation, manifesting in task‐evoked and neurodegenerative changes. We propose that a profile of disorientation across multiple domains offers a unique window into the progression of AD and as such could greatly benefit disease diagnosis, monitoring, and evaluation of treatment response. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Odor identification score as an alternative method for early identification of amyloidogenesis in Alzheimer's disease.
- Author
-
Igeta, Yukifusa, Hemmi, Isao, Yuyama, Kohei, and Ouchi, Yasuyoshi
- Subjects
- *
ODORS , *ALZHEIMER'S disease , *AMNESTIC mild cognitive impairment , *APOLIPOPROTEIN E , *APOLIPOPROTEIN E4 , *TAU proteins , *PRESENILINS , *CEREBROSPINAL fluid - Abstract
A simple screening test to identify the early stages of Alzheimer's disease (AD) is urgently needed. We investigated whether odor identification impairment can be used to differentiate between stages of the A/T/N classification (amyloid, tau, neurodegeneration) in individuals with amnestic mild cognitive impairment or AD and in healthy controls. We collected data from 132 Japanese participants visiting the Toranomon Hospital dementia outpatient clinic. The odor identification scores correlated significantly with major neuropsychological scores, regardless of apolipoprotein E4 status, and with effective cerebrospinal fluid (CSF) biomarkers [amyloid β 42 (Aβ42) and the Aβ42/40 and phosphorylated Tau (p-Tau)/Aβ42 ratios] but not with ineffective biomarkers [Aβ40 and the p-Tau/total Tau ratio]. A weak positive correlation was observed between the corrected odor identification score (adjusted for age, sex, ApoE4 and MMSE), CSF Aβ42, and the Aβ42/40 ratio. The odor identification score demonstrated excellent discriminative power for the amyloidogenesis stage , according to the A/T/N classification, but was unsuitable for differentiating between the p-Tau accumulation and the neurodegeneration stages. After twelve odor species were analyzed, a version of the score comprising only four odors—India ink, wood, curry, and sweaty socks—proved highly effective in identifying AD amyloidogenesis, showing promise for the screening of preclinical AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Higher remnant cholesterol is associated with an increased risk of amnestic mild cognitive impairment: a community-based cross-sectional study.
- Author
-
Yating Ai, Chunyi Zhou, Ming Wang, Chongming Yang, Shi Zhou, Xinxiu Dong, Niansi Ye, Yucan Li, Ling Wang, Hairong Ren, Xiaolian Gao, Man Xu, Hui Hu, and Yuncui Wang
- Subjects
RESEARCH ,KEY performance indicators (Management) ,CONFIDENCE intervals ,MILD cognitive impairment ,CROSS-sectional method ,COMMUNITY health services ,RISK assessment ,T-test (Statistics) ,INDEPENDENT living ,CLINICAL medicine ,DESCRIPTIVE statistics ,RESEARCH funding ,LOGISTIC regression analysis ,ODDS ratio ,STATISTICAL correlation ,RECEIVER operating characteristic curves ,DATA analysis software ,SENSITIVITY & specificity (Statistics) ,CHOLESTEROL ,AMNESIA ,DISEASE risk factors ,OLD age - Abstract
Background and aims: Amnestic mild cognitive impairment (aMCI) is the most common subtype of MCI, which carries a significantly high risk of transitioning to Alzheimer's disease. Recently, increasing attention has been given to remnant cholesterol (RC), a non-traditional and previously overlooked risk factor. The aim of this study was to explore the association between plasma RC levels and aMCI. Methods: Data were obtained from Brain Health Cognitive Management Team in Wuhan (https://hbtcm.66nao.com/admin). A total of 1,007 community-dwelling elders were recruited for this project. Based on ten tools including general demographic data, cognitive screening and some exclusion scales, these participants were divided into the aMCI (n = 401) and normal cognitive groups (n = 606). Physical examinations were conducted on all participants, with clinical indicators such as blood pressure, blood sugar, and blood lipids collected. Results: The aMCI group had significantly higher RC levels compared to the normal cognitive group (0.64 ± 0.431 vs. 0.52 ± 0.447 mmol/L, p<0.05). Binary logistics regression revealed that occupation (P<0.001, OR = 0.533, 95%CI: 0.423-0.673) and RC (p = 0.014, OR = 1.477, 95% CI:1.081-2.018) were associated factors for aMCI. Partial correlation analysis, after controlling for occupation, showed a significant negative correlation between RC levels and MoCA scores (r = 0.059, p = 0.046), as well as Naming scores (r = 0.070, p = 0.026). ROC curve analysis demonstrated that RC levels had an independent predictive efficacy in predicting aMCI (AUC = 0.580, 95%CI: 0.544 ~ 0.615, P <0.001). Conclusion: Higher RC levels were identified as an independent indicator for aMCI, particularly in the naming cognitive domain among older individuals. Further longitudinal studies are necessary to validate the predictive efficacy of RC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Repetitive transcranial magnetic stimulation regulates effective connectivity patterns of brain networks in the spectrum of preclinical Alzheimer's disease.
- Author
-
Xuhong Liang, Chen Xue, Darui Zheng, Qianqian Yuan, Wenzhang Qi, Yiming Ruan, Shanshan Chen, Yu Song, Huimin Wu, Xiang Lu, Chaoyong Xiao, and Jiu Chen
- Subjects
ALZHEIMER'S disease treatment ,BRAIN ,TRANSCRANIAL magnetic stimulation ,CROSS-sectional method ,RESEARCH funding - Abstract
Objectives: Subjective cognitive decline (SCD) and amnestic mild cognitive impairment (aMCI) are considered as the spectrum of preclinical Alzheimer's disease (AD), with abnormal brain network connectivity as the main neuroimaging feature. Repetitive transcranial magnetic stimulation (rTMS) has been proven to be an effective non-invasive technique for addressing neuropsychiatric disorders. This study aims to explore the potential of targeted rTMS to regulate effective connectivity within the default mode network (DMN) and the executive control network (CEN), thereby improving cognitive function. Methods: This study included 86 healthy controls (HCs), 72 SCDs, and 86 aMCIs. Among them, 10 SCDs and 11 aMCIs received a 2-week rTMS course of 5-day, once-daily. Cross-sectional analysis with the spectral dynamic causal model (spDCM) was used to analyze the DMN and CEN effective connectivity patterns of the three groups. Afterwards, longitudinal analysis was conducted on the changes in effective connectivity patterns and cognitive function before and after rTMS for SCD and aMCI, and the correlation between them was analyzed. Results: Cross-sectional analysis showed different effective connectivity patterns in the DMN and CEN among the three groups. Longitudinal analysis showed that the effective connectivity pattern of the SCD had changed, accompanied by improvements in episodic memory. Correlation analysis indicated a negative relationship between effective connectivity from the left angular gyrus (ANG) to the anterior cingulate gyrus and the ANG.R to the right middle frontal gyrus, with visuospatial and executive function, respectively. In patients with aMCI, episodic memory and executive function improved, while the effective connectivity pattern remained unchanged. Conclusion: This study demonstrates that PCUN-targeted rTMS in SCD regulates the abnormal effective connectivity patterns in DMN and CEN, thereby improving cognition function. Conversely, in aMCI, the mechanism of improvement may differ. Our findings further suggest that rTMS is more effective in preventing or delaying disease progression in the earlier stages of the AD spectrum. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Meta-analysis of Montreal cognitive assessment diagnostic accuracy in amnestic mild cognitive impairment.
- Author
-
Malek-Ahmadi, Michael and Nikkhahmanesh, Nia
- Subjects
AMNESTIC mild cognitive impairment ,MONTREAL Cognitive Assessment ,EDINBURGH Postnatal Depression Scale ,COGNITION disorders ,MEDICAL screening ,MILD cognitive impairment - Abstract
Background: The Montreal Cognitive Assessment (MoCA) is one of the most widely-used cognitive screening instruments and has been translated into several different languages and dialects. Although the original validation study suggested to use a cutoff of ≤26, subsequent studies have shown that lower cutoff values may yield fewer false-positive indications of cognitive impairment. The aim of this study was to summarize the diagnostic accuracy and mean difference of the MoCA when comparing cognitively unimpaired (CU) older adults to those with amnestic mild cognitive impairment (aMCI). Methods: PubMed and EMBASE databases were searched from inception to 22 February 2022. Meta-analyses for area under the curve (AUC) and standardized mean difference (SMD) values were performed. Results: Fifty-five observational studies that included 17,343 CU and 8,413 aMCI subjects were selected for inclusion. Thirty-nine studies were used in the AUC analysis while 44 were used in the SMD analysis. The overall AUC value was 0.84 (95% CI: 0.81, 0.87) indicating good diagnostic accuracy and a large effect size was noted for the SMD analysis (Hedge’s g = 1.49, 95% CI: 1.33, 1.64). Both analyses had high levels of between-study heterogeneity. The median cutoff score for identifying aMCI was <24. Discussion and conclusion: The MoCA has good diagnostic accuracy for detecting aMCI across several different languages. The findings of this metaanalysis also support the use of 24 as the optimal cutoff when the MoCA is used to screen for suspected cognitive impairment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Metacognitive beliefs of efficacy about daily life situations and use of cognitive strategies in amnestic mild cognitive impairment: a cross-sectional study.
- Author
-
Bampa, Grigoria, Moraitou, Despina, Metallidou, Panagiota, Masoura, Elvira, Papantoniou, Georgia, Sofologi, Maria, Kougioumtzis, Georgios, Papatzikis, Efthymios, and Tsolaki, Magdalini
- Subjects
AMNESTIC mild cognitive impairment ,METACOGNITION ,MILD cognitive impairment ,EVERYDAY life ,CROSS-sectional method ,QUALITY of life - Abstract
Metacognition, the ability to monitor and regulate cognitive processes, is essential for individuals with Mild Cognitive Impairment (MCI) to accurately identify their deficits and effectively manage them. However, previous studies primarily focused on memory awareness in MCI, neglecting other domains affected in daily life. This study aimed to investigate how individuals with MCI perceive their abilities to handle various cognitively challenging situations representing real-life scenarios and their use of compensatory strategies. Thus 100 participants were recruited, including 50 with amnestic MCI with multiple deficits (aMCI) and 50 cognitively healthy controls (HC) matched in age and education. Participants completed three metacognitive scales assessing self-perceived efficacy in everyday life scenarios and one scale evaluating use of cognitive strategies. Results indicated that aMCI participants reported significantly lower self-efficacy in memory and divided-shifted attention scenarios compared to HC. Surprisingly, no significant group differences were found in the self-reports about the use of cognitive strategies. This suggests a potential gap in understanding or applying effective strategies for compensating cognitive deficits. These findings emphasize the importance of cognitive training programs targeting metacognitive knowledge enhancement and practical use of cognitive strategies that could enhance the quality of life for individuals with MCI. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Profiles of subgingival microbiomes and gingival crevicular metabolic signatures in patients with amnestic mild cognitive impairment and Alzheimer's disease.
- Author
-
Qiu, Che, Zhou, Wei, Shen, Hui, Wang, Jintao, Tang, Ran, Wang, Tao, Xie, Xinyi, Hong, Bo, Ren, Rujing, Wang, Gang, and Song, Zhongchen
- Subjects
- *
AMNESTIC mild cognitive impairment , *PORPHYROMONAS gingivalis , *ALZHEIMER'S disease , *LIQUID chromatography-mass spectrometry - Abstract
Background: The relationship between periodontitis and Alzheimer's disease (AD) has attracted more attention recently, whereas profiles of subgingival microbiomes and gingival crevicular fluid (GCF) metabolic signatures in AD patients have rarely been characterized; thus, little evidence exists to support the oral-brain axis hypothesis. Therefore, our study aimed to characterize both the microbial community of subgingival plaque and the metabolomic profiles of GCF in patients with AD and amnestic mild cognitive impairment (aMCI) for the first time. Methods: This was a cross-sectional study. Clinical examinations were performed on all participants. The microbial community of subgingival plaque and the metabolomic profiles of GCF were characterized using the 16S ribosomal RNA (rRNA) gene high-throughput sequencing and liquid chromatography linked to tandem mass spectrometry (LC–MS/MS) analysis, respectively. Results: Thirty-two patients with AD, 32 patients with aMCI, and 32 cognitively normal people were enrolled. The severity of periodontitis was significantly increased in AD patients compared with aMCI patients and cognitively normal people. The 16S rRNA gene sequencing results showed that the relative abundances of 16 species in subgingival plaque were significantly correlated with cognitive function, and LC–MS/MS analysis identified a total of 165 differentially abundant metabolites in GCF. Moreover, multiomics Data Integration Analysis for Biomarker discovery using Latent cOmponents (DIABLO) analysis revealed that 19 differentially abundant metabolites were significantly correlated with Veillonella parvula, Dialister pneumosintes, Leptotrichia buccalis, Pseudoleptotrichia goodfellowii, and Actinomyces massiliensis, in which galactinol, sn-glycerol 3-phosphoethanolamine, D-mannitol, 1 h-indole-1-pentanoic acid, 3-(1-naphthalenylcarbonyl)- and L-iditol yielded satisfactory accuracy for the predictive diagnosis of AD progression. Conclusions: This is the first combined subgingival microbiome and GCF metabolome study in patients with AD and aMCI, which revealed that periodontal microbial dysbiosis and metabolic disorders may be involved in the etiology and progression of AD, and the differential abundance of the microbiota and metabolites may be useful as potential markers for AD in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Special Issue "Role of Apoptosis and Cellular Senescence in Cancer and Aging".
- Author
-
Tzoneva, Rumiana
- Subjects
- *
CELLULAR aging , *AGING , *APOPTOSIS , *DNA repair , *AMNESTIC mild cognitive impairment , *AURORA kinases - Abstract
This document is a special issue of the International Journal of Molecular Sciences that focuses on the role of apoptosis and cellular senescence in cancer and aging. It explains that apoptosis and senescence are cellular responses to irreversible dysfunctions caused by cellular damage, and their functions change over time. In the early stages of life, they function as tumor suppression mechanisms, but later in life, they become destructive and promote aging. The document also discusses the role of cellular senescence in neurodegenerative diseases like Alzheimer's and its potential link to cancer. It concludes by highlighting the need to understand the delicate balance between apoptosis and cellular senescence for the development of future anti-cancer and aging strategies. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
46. Prevalence, cognitive characteristics, and influencing factors of amnestic mild cognitive impairment among older adults residing in an urban community in Chengdu, China.
- Author
-
Shan Rao, Yan Cai, Zhujun Zhong, Tianyuan Gou, Yangyang Wang, Shiyi Liao, Peiyuan Qiu, and Weihong Kuang
- Subjects
AMNESTIC mild cognitive impairment ,OLDER people ,VERBAL learning ,MILD cognitive impairment ,LONG-term memory ,ALZHEIMER'S disease ,TRAIL Making Test - Abstract
Objective: Dementia is a significant public health concern, and mild cognitive impairment (MCI) serves as a transitional stage between normal aging and dementia. Among the various types of MCI, amnestic MCI (aMCI) has been identified as having a higher likelihood of progressing to Alzheimer's dimension. However, limited research has been conducted on the prevalence of aMCI in China. Therefore, the objective of this study is to investigate the prevalence of aMCI, examine its cognitive characteristics, and identify associated risk factors. Methods: In this cross-sectional study, we investigated a sample of 368 older adults aged 60 years and above in the urban communities of Chengdu, China. The participants underwent a battery of neuropsychological assessments, including the Mini-Mental State Examination (MMSE), the Clinical Dementia Rating (CDR), Auditory Verbal Learning Test (AVLT), Wechsler's Logical Memory Task (LMT), Boston Naming Test (BNT) and Trail Making Test Part A (TMT-A). Social information was collected by standard questionnaire. Multiple logistic regression analysis was utilized to screen for the risk and protective factors of aMCI. Results: The data analysis included 309 subjects with normal cognitive function and 59 with aMCI, resulting in a prevalence of 16.0% for aMCI. The average age of participants was 69.06 ± 7.30 years, with 56.0% being females. After controlling for age, gender and education, the Spearman partial correlation coefficient between various cognitive assessments and aMCI ranged from -0.52 for the long-term delayed recall scores in AVLT to 0.19 for the time-usage scores in TMT-A. The results indicated that all cognitive domains, except for naming scores (after semantic cue of BNT) and error quantity (in TMT-A), showed statistically significant associations with aMCI. Furthermore, the multiple logistic regression analysis revealed that older age (OR = 1.044, 95%CI: 1.002~1.087), lower educational level, and diabetes (OR = 2.450, 95%CI: 1.246~4.818) were risk factors of aMCI. Conclusion: This study found a high prevalence of aMCI among older adults in Chengdu, China. Individuals with aMCI exhibited lower cognitive function in memory, language, and executive domains, with long-term delayed recall showing the strongest association. Clinicians should prioritize individuals with verbal learning and memory difficulties, especially long-term delayed recall, in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Predictive power of gait and gait-related cognitive measures in amnestic mild cognitive impairment: a machine learning analysis.
- Author
-
Tuena, Cosimo, Pupillo, Chiara, Stramba-Badiale, Chiara, Stramba-Badiale, Marco, and Riva, Giuseppe
- Subjects
AMNESTIC mild cognitive impairment ,MACHINE learning ,ALZHEIMER'S disease ,K-nearest neighbor classification ,GAIT disorders ,SUPPORT vector machines - Abstract
Introduction: Gait disorders and gait-related cognitive tests were recently linked to future Alzheimer’s Disease (AD) dementia diagnosis in amnestic Mild Cognitive Impairment (aMCI). This study aimed to evaluate the predictive power of gait disorders and gait-related neuropsychological performances for future AD diagnosis in aMCI through machine learning (ML). Methods: A sample of 253 aMCI (stable, converter) individuals were included. We explored the predictive accuracy of four predictors (gait profile plus MMSE, DSST, and TMT-B) previously identified as critical for the conversion from aMCI to AD within a 36-month follow-up. Supervised ML algorithms (Support Vector Machine [SVM], Logistic Regression, and k-Nearest Neighbors) were trained on 70% of the dataset, and feature importance was evaluated for the best algorithm. Results: The SVM algorithm achieved the best performance. The optimized training set performance achieved an accuracy of 0.67 (sensitivity = 0.72; specificity = 0.60), improving to 0.70 on the test set (sensitivity = 0.79; specificity = 0.52). Feature importance revealed MMSE as the most important predictor in both training and testing, while gait type was important in the testing phase. Discussion: We created a predictive ML model that is capable of identifying aMCI at high risk of AD dementia within 36 months. Our ML model could be used to quickly identify individuals at higher risk of AD, facilitating secondary prevention (e.g., cognitive and/or physical training), and serving as screening for more expansive and invasive tests. Lastly, our results point toward theoretically and practically sound evidence of mind and body interaction in AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Modified RCTU Score: A Semi-Quantitative, Visual Tool for Predicting Alzheimer's Conversion from aMCI.
- Author
-
Chong, Ari, Ha, Jung-Min, Chung, Ji Yeon, Kim, Hoowon, and Choo, IL Han
- Subjects
- *
ALZHEIMER'S disease , *AMNESTIC mild cognitive impairment , *AMYLOID plaque , *POSITRON emission tomography - Abstract
This research evaluated the modified RCTU score, derived from amyloid PET scans, for predicting the progression from amnestic Mild Cognitive Impairment (aMCI) to Alzheimer's Disease (AD). aMCI patients underwent baseline evaluations, including amyloid PET. AD conversion was identified through neuropsychological tests after observation. The RCTU was modified by segmenting frontal, parietal, and temporal lobes into left and right, resulting in seven areas. Scores from both modified and conventional RCTU were analyzed and compared. Among 45 patients, 12 progressed to AD (over 17.8 ± 6.8 months). AD converters showed higher scores in modified RCTU scores. Modified RCTU score had strong correlations with amyloid SUVR (r > 0.7). Modified RCTU sum score was the significant covariate of AD conversion. Modified RCTU could determine the asymmetry of amyloid deposits. We demonstrated that symmetric deposits of amyloid showed a higher risk for AD conversion when analyzed using modified RCTU. The modified RCTU score is a promising method for predicting AD conversion, correlating strongly with amyloid SUVR. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. An Examination of the Motives for Attributing and Interpreting Deception in People with Amnestic Mild Cognitive Impairment.
- Author
-
Tilkeridou, Maria, Moraitou, Despina, Papaliagkas, Vasileios, Frantzi, Nikoleta, Emmanouilidou, Evdokia, and Tsolaki, Magdalini
- Subjects
- *
AMNESTIC mild cognitive impairment , *MILD cognitive impairment , *LIE detectors & detection , *DECEPTION , *YOUNG adults , *DAY care centers , *ALZHEIMER'S disease - Abstract
The aim of the present study was to examine how a person with amnestic mild cognitive impairment perceives the phenomenon of deception. Amnestic mild cognitive impairment (aMCI) usually represents the prodromal phase of Alzheimer's disease (AD), with patients showing memory impairment but with normal activities of daily living. It was expected that aMCI patients would face difficulties in the attribution and interpretation of deceptive behavior due to deficits regarding their diagnosis. The main sample of the study consisted of 76 older adults who were patients of a daycare center diagnosed with aMCI. A sample of 55 highly educated young adults was also examined in the same experiment to qualitatively compare their performance with that of aMCI patients. Participants were assigned a scenario where a hypothetical partner (either a friend or a stranger) was engaged in a task in which the partner could lie to boost their earnings at the expense of the participant. The results showed that aMCI patients, even if they understood that something was going wrong, did not invest in interpretations of potential deception and tended to avoid searching for confirmative information related to the hypothetical lie of their partner compared to highly educated young adults. It seems that aMCI patients become somehow "innocent", and this is discussed in terms of cognitive impairment and/or socioemotional selectivity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Functional magnetic resonance imaging study during resting state and visual oddball task in mild cognitive impairment.
- Author
-
Kemik, Kerem, Ada, Emel, Çavuşoğlu, Berrin, Aykaç, Cansu, Emek‐Savaş, Derya Durusu, and Yener, Görsev
- Subjects
- *
FUNCTIONAL magnetic resonance imaging , *MILD cognitive impairment , *AMNESTIC mild cognitive impairment , *FRONTOPARIETAL network , *LARGE-scale brain networks - Abstract
Background: Amnestic mild cognitive impairment (aMCI) is a transitional state between normal aging and dementia, and identifying early biomarkers is crucial for disease detection and intervention. Functional magnetic resonance imaging (fMRI) has the potential to identify changes in neural activity in MCI. Methods: We investigated neural activity changes in the visual network of the aMCI patients (n:20) and healthy persons (n:17) using resting‐state fMRI and visual oddball task fMRI. We used independent component analysis to identify regions of interest and compared the activity between groups using a false discovery rate correction. Results: Resting‐state fMRI revealed increased activity in the areas that have functional connectivity with the visual network, including the right superior and inferior lateral occipital cortex, the right angular gyrus and the temporo‐occipital part of the right middle temporal gyrus (p‐FDR = 0.008) and decreased activity in the bilateral thalamus and caudate nuclei, which are part of the frontoparietal network in the aMCI group (p‐FDR = 0.002). In the visual oddball task fMRI, decreased activity was found in the right frontal pole, the right frontal orbital cortex, the left superior parietal lobule, the right postcentral gyrus, the right posterior part of the supramarginal gyrus, the right superior part of the lateral occipital cortex, and the right angular gyrus in the aMCI group. Conclusion: Our results suggest the alterations in the visual network are present in aMCI patients, both during resting‐state and task‐based fMRI. These changes may represent early biomarkers of aMCI and highlight the importance of assessing visual processing in cognitive impairment. However, future studies with larger sample sizes and longitudinal designs are needed to confirm these findings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.